메뉴 건너뛰기




Volumn 49, Issue 5, 2006, Pages 1115-1116

Proteoglycans can mediate renal lipoprotein retention [4]

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; PROTEOGLYCAN;

EID: 33646419831     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0181-z     Document Type: Letter
Times cited : (5)

References (8)
  • 1
    • 0025831857 scopus 로고
    • Immunohistological localization of apolipoproteins in the glomeruli in renal disease: Specifically apoB and apoE
    • Sato H, Suzuki S, Kobayashi H, Ogino S, Inomata A, Arakawa M (1991) Immunohistological localization of apolipoproteins in the glomeruli in renal disease: specifically apoB and apoE. Clin Nephrol 36:127-133
    • (1991) Clin Nephrol , vol.36 , pp. 127-133
    • Sato, H.1    Suzuki, S.2    Kobayashi, H.3    Ogino, S.4    Inomata, A.5    Arakawa, M.6
  • 2
    • 0035292906 scopus 로고    scopus 로고
    • Small proteoglycans in human diabetic nephropathy: Discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin
    • Schaefer L, Raslik I, Grone HJ et al (2001) Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J 15:559-561
    • (2001) FASEB J , vol.15 , pp. 559-561
    • Schaefer, L.1    Raslik, I.2    Grone, H.J.3
  • 3
    • 2942566484 scopus 로고    scopus 로고
    • Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans
    • Tannock LR, Little PJ, Tsoi C, Barrett PH, Wight TN, Chait A (2004) Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans. Diabetologia 47:837-843
    • (2004) Diabetologia , vol.47 , pp. 837-843
    • Tannock, L.R.1    Little, P.J.2    Tsoi, C.3    Barrett, P.H.4    Wight, T.N.5    Chait, A.6
  • 4
    • 0347511753 scopus 로고    scopus 로고
    • Mediators of diabetic renal disease: The case for TGF-beta as the major mediator
    • Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for TGF-beta as the major mediator. J Am Soc Nephrol 15 (Suppl 1):S55-S57
    • (2004) J Am Soc Nephrol , vol.15 , Issue.1 SUPPL.
    • Ziyadeh, F.N.1
  • 5
    • 0036143394 scopus 로고    scopus 로고
    • Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs
    • Little PJ, Tannock L, Olin KL, Chait A, Wight TN (2002) Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs. Arterioscler Thromb Vasc Biol 22:55-60
    • (2002) Arterioscler Thromb Vasc Biol , vol.22 , pp. 55-60
    • Little, P.J.1    Tannock, L.2    Olin, K.L.3    Chait, A.4    Wight, T.N.5
  • 6
    • 0025138512 scopus 로고
    • Transforming growth factor-beta regulates production of proteoglycans by mesangial cells
    • Border WA, Okuda S, Languino LR, Ruoslahti E (1990) Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695
    • (1990) Kidney Int , vol.37 , pp. 689-695
    • Border, W.A.1    Okuda, S.2    Languino, L.R.3    Ruoslahti, E.4
  • 7
    • 0027437695 scopus 로고
    • Interactions between lipoproteins, glomerular cells and matrix
    • Wheeler DC, Chana RS (1993) Interactions between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 19:149-164
    • (1993) Miner Electrolyte Metab , vol.19 , pp. 149-164
    • Wheeler, D.C.1    Chana, R.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.